What are ‘tissue ACE inhibitors,’ and should they be used instead of other ACE inhibitors?

Gary S. Francis, MD
Director, Coronary Intensive Care Unit, Department of Cardiology, Cleveland Clinic

John P. Gassler, MD
Interventional Fellow in Cardiology, University of Rochester, Strong Memorial Hospital, Rochester, New York

Address: Gary S. Francis, MD, Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Gary S. Francis, MD
Director, Coronary Intensive Care Unit, Department of Cardiology, Cleveland Clinic

John P. Gassler, MD
Interventional Fellow in Cardiology, University of Rochester, Strong Memorial Hospital, Rochester, New York

Address: Gary S. Francis, MD, Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Gary S. Francis, MD
Director, Coronary Intensive Care Unit, Department of Cardiology, Cleveland Clinic

John P. Gassler, MD
Interventional Fellow in Cardiology, University of Rochester, Strong Memorial Hospital, Rochester, New York

Address: Gary S. Francis, MD, Department of Cardiology, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195